CHKA
Basic information
Region (hg38): 11:68052859-68121444
Previous symbols: [ "CHK" ]
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures (Limited), mode of inheritance: AR
- neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures (Strong), mode of inheritance: AR
- neurodevelopmental disorder (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic; Ophthalmologic | 35202461 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CHKA gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 29 | 33 | ||||
nonsense | 0 | |||||
start loss | 1 | |||||
frameshift | 1 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 4 | 31 | 2 | 0 |
Variants in CHKA
This is a list of pathogenic ClinVar variants found in the CHKA region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-68054006-C-A | not specified | Uncertain significance (Nov 07, 2024) | ||
11-68061977-A-G | Likely benign (Mar 01, 2023) | |||
11-68064604-C-T | not specified | Uncertain significance (Aug 30, 2021) | ||
11-68065890-A-G | Seizure;Intellectual disability, severe;Microcephaly • Neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures | Likely pathogenic (Aug 08, 2024) | ||
11-68066469-G-T | not specified | Uncertain significance (Feb 28, 2024) | ||
11-68066483-G-C | not specified | Uncertain significance (Sep 06, 2024) | ||
11-68066492-C-T | not specified | Likely benign (Jul 02, 2024) | ||
11-68068914-G-C | not specified | Uncertain significance (Dec 02, 2024) | ||
11-68070196-T-A | not specified | Uncertain significance (Apr 04, 2024) | ||
11-68070216-T-C | not specified | Uncertain significance (Dec 01, 2022) | ||
11-68070245-A-C | not specified | Uncertain significance (Nov 23, 2022) | ||
11-68070752-G-A | not specified | Uncertain significance (Sep 10, 2024) | ||
11-68070768-C-G | not specified | Uncertain significance (May 23, 2023) | ||
11-68070800-C-T | Neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures | Uncertain significance (Nov 22, 2023) | ||
11-68070845-C-T | not specified | Uncertain significance (Sep 07, 2022) | ||
11-68074767-G-A | Seizure;Intellectual disability, severe;Microcephaly • Neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures | Likely pathogenic (Oct 15, 2021) | ||
11-68074785-C-T | not specified | Uncertain significance (Dec 13, 2022) | ||
11-68074799-A-G | not specified | Uncertain significance (Aug 22, 2023) | ||
11-68097060-G-A | Seizure;Intellectual disability, severe;Microcephaly • Neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures | Likely pathogenic (Oct 15, 2021) | ||
11-68120868-G-C | not specified | Uncertain significance (Aug 07, 2024) | ||
11-68120925-G-A | not specified | Uncertain significance (May 09, 2022) | ||
11-68120954-G-A | not specified | Uncertain significance (May 08, 2023) | ||
11-68120964-G-A | not specified | Uncertain significance (Dec 14, 2021) | ||
11-68120965-C-G | not specified | Uncertain significance (Sep 21, 2023) | ||
11-68120968-GGGCAGC-G | Neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures | Uncertain significance (Nov 22, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CHKA | protein_coding | protein_coding | ENST00000265689 | 12 | 68586 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.227 | 0.772 | 125733 | 0 | 15 | 125748 | 0.0000596 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.00 | 163 | 203 | 0.802 | 0.0000103 | 2986 |
Missense in Polyphen | 50 | 89.472 | 0.55883 | 1284 | ||
Synonymous | 0.740 | 68 | 76.2 | 0.892 | 0.00000409 | 854 |
Loss of Function | 3.49 | 6 | 24.7 | 0.243 | 0.00000130 | 305 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000580 | 0.0000580 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000467 | 0.0000462 |
European (Non-Finnish) | 0.0000617 | 0.0000615 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000107 | 0.0000980 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Has a key role in phospholipid biosynthesis and may contribute to tumor cell growth. Catalyzes the first step in phosphatidylcholine biosynthesis. Contributes to phosphatidylethanolamine biosynthesis. Phosphorylates choline and ethanolamine. Has higher activity with choline. {ECO:0000269|PubMed:19915674}.;
- Pathway
- Glycerophospholipid metabolism - Homo sapiens (human);Choline metabolism in cancer - Homo sapiens (human);Phospholipid Biosynthesis;Kennedy pathway from Sphingolipids;One carbon metabolism and related pathways;Acetylcholine Synthesis;Metabolism of lipids;phosphatidylcholine biosynthesis;Metabolism;Synthesis of PC;Synthesis of PE;phosphatidylcholine biosynthesis pathway;Glycerophospholipid biosynthesis;Phospholipid metabolism
(Consensus)
Recessive Scores
- pRec
- 0.261
Intolerance Scores
- loftool
- 0.603
- rvis_EVS
- -0.43
- rvis_percentile_EVS
- 25.37
Haploinsufficiency Scores
- pHI
- 0.210
- hipred
- Y
- hipred_score
- 0.728
- ghis
- 0.562
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.919
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Chka
- Phenotype
- homeostasis/metabolism phenotype; liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- ethanolamine metabolic process;lipid metabolic process;phosphatidylethanolamine biosynthetic process;phosphatidylcholine biosynthetic process;CDP-choline pathway;lipid transport;response to toxic substance;phosphorylation;choline metabolic process;response to 3-methylcholanthrene
- Cellular component
- cytosol
- Molecular function
- choline kinase activity;cholinesterase activity;ethanolamine kinase activity;ATP binding;drug binding;choline binding;protein homodimerization activity